Small-molecule FRET probes for protein kinase activity monitoring in living cells

Biochemical and Biophysical Research Communications

Volumn 397, Issue 4, 2010, Pages 750-755

  Vaasa, Angela ^a   Lust, Marje ^a   Terrin, Anna ^b   Uri, Asko ^a   Zaccolo, Manuela ^b  

^a UNIVERSITY OF TARTU   (Estonia)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

CAMP; CAMP dependent protein kinase; Fluorescence; FRET; Living cells; Small molecule fluorescent probe; YFP

Indexed keywords

ADENOSINE DERIVATIVE; ARGININE DERIVATIVE; CYCLIC AMP DEPENDENT PROTEIN KINASE; HYBRID PROTEIN; YELLOW FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; ENERGY TRANSFER; ENZYME ACTIVITY; ENZYME ANALYSIS; FOERSTER RESONANCE ENERGY TRANSFER; MEMBRANE TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT;

ADENOSINE; ARGININE; BACTERIAL PROTEINS; CELL MEMBRANE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FLUORESCENCE RESONANCE ENERGY TRANSFER; FLUORESCENT DYES; HUMANS; LUMINESCENT PROTEINS; MICROSCOPY, FLUORESCENCE; OLIGOPEPTIDES;

EID: 77954387047     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.026     Document Type: Article

References (23)

1. Cohen P. Protein kinases: the major drug targets of the twenty first century?. Nat. Rev. Drug Discovery 2002, 1:309-315.
2. Fedorov O., Muller S., Knapp S. The (un)targeted cancer kinome. Nat. Chem. Biol. 2010, 6:166-169.
3. Gasparri F., Sola F., Bandiera T., Moll J., Galvani A. High-content analysis of kinase activity in cells. Comb. Chem. High Throughput Screening 2008, 7:523-536.
4. Allen M.D., DiPilato L.M., Rahdar M., Ren Y.R., Chong C., Liu J.O., Zhang J. Reading dynamic kinase activity in living cells for high-throughput screening. ACS Chem. Biol. 2006, 6:371-376.
5. Viht K., Schweinsberg S., Lust M., Vaasa A., Raidaru G., Lavõgina D., Uri A., Herberg F.W. Surface-plasmon-resonance-based biosensor with immobilized bisubstrate analog inhibitor for the determination of affinities of ATP- and protein-competitive ligands of cAMP-dependent protein kinase. Anal. Biochem. 2007, 362:268-277.
6. Vaasa A., Viil I., Enkvist E., Viht K., Raidaru G., Lavõgina D., Uri A. High-affinity bisubstrate probe for fluorescence anisotropy binding/displacement assays with protein kinases PKA and ROCK. Anal. Biochem. 2009, 385:85-93.
7. Lavõgina D., Nickl C.K., Enkvist E., Raidaru G., Lust M., Vaasa A., Uri A., Dostmann W.R. Adenosine analogue-oligo-arginine conjugates (ARCs) serve as high-affinity inhibitors and fluorescence probes of type I cGMP-dependent protein kinase (PKGIα). Biochim. Biophys. Acta 2010, 10.1016/j.bbapap.2010.04.007.
8. Lavogina D., Lust M., Viil I., König N., Raidaru G., Rogozina J., Enkvist E., Uri A., Bossemeyer D. Structural analysis of ARC-type inhibitor (ARC-1034) binding to protein kinase A catalytic subunit and rational design of bisubstrate analogue inhibitors of basophilic protein kinases. J. Med. Chem. 2009, 52:308-321.
9. Nakase I., Takeuchi T., Tanaka G., Futaki S. Methodological and cellular aspects that govern the internalization mechanisms of arginine-rich cell-penetrating peptides. Adv. Drug Deliv. Rev. 2008, 60:598-607.
10. Förster T. Intermolecular energy transfer and fluorescence. Ann. Phys. 1948, 2:55-75.
11. Lakowicz J.R. Principles of Fluorescence Spectroscopy 2006, Springer Science, New York. third ed.
12. Li Y., Xie W., Fang G. Fluorescence detection techniques for protein kinase assay. Anal. Bioanal. Chem. 2008, 390:2049-2057.
13. Zaccolo M., De Giorgi F., Cho C.Y., Feng L., Knapp T., A Negulescu P., Taylor S.S., Tsien R.Y., Pozzan T. A genetically encoded fluorescent indicator for cyclic AMP in living cells. Nat. Cell Biol. 2000, 2:25-29.
14. Enkvist E., Lavogina D., Raidaru G., Vaasa A., Viil I., Lust M., Viht K., Uri A. Conjugation of adenosine and hexa-(d-arginine) leads to a nanomolar bisubstrate-analog inhibitor of basophilic protein kinases. J. Med. Chem. 2006, 49:7150-7159.
15. Adams S.R., Harootunian A.T., Buechler Y.J., Taylor S.S., Tsien R.Y. Fluorescence ratio imaging of cyclic AMP in single cells. Nature 1991, 349:694-697.
16. Lissandron V., Terrin A., Collini M., D'Alfonso L., Chirico G., Pantano S., Zaccolo M. Improvement of a FRET-based indicator for cAMP by linker design and stabilization of donor-acceptor interaction. J. Mol. Biol. 2005, 354:546-555.
17. Zaccolo M., Pozzan T. Discrete microdomains with high concentration of cAMP in stimulated rat neonatal cardiac myocytes. Science 2002, 295:1711-1715.
18. Lebakken C.S., Riddle S.M., Singh U., Frazee W.J., Eliason H.C., Gao Y., Reichling L.J., Marks B.D., Vogel K.W. Development and applications of a broad-coverage, TR-FRET-based kinase binding assay platform. J. Biomol. Screen. 2009, 14:924-935.
19. Heitz F., Morris M.C., Divita G. Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics. Br. J. Pharmacol. 2009, 157:195-206.
20. Uri A., Raidaru G., Subbi J., Padari K., Pooga M. Identification of the ability of highly charged nanomolar inhibitors of protein kinases to cross plasma membranes and carry a protein into cells. Bioorg. Med. Chem. Lett. 2002, 12:2117-2120.
21. Fischer R., Waizenegger T., Köhler K., Brock R. A quantitative validation of fluorophore-labelled cell-permeable peptide conjugates: fluorophore and cargo dependence of import. Biochim. Biophys. Acta 2002, 1564:365-374.
22. Pucket C.A., Barton J.K. Fluorescein redirects a ruthenium-octaarginine conjugate to the nucleus. J. Am. Chem. Soc. 2009, 131:8738-8739.
23. Kosuge M., Takeuchi T., Nakase I., Jones A.T., Futaki S. Cellular internalization and distribution of arginine-rich peptides as a function of extracellular peptide concentration, serum, and plasma membrane associated proteoglycans. Bioconjug. Chem. 2008, 19:656-664.